PMID: 8977674Nov 1, 1996Paper

Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study

The British Journal of Dermatology
G KirtschigF Wojnarowska

Abstract

Clinical, immunopathological and immunogenetic studies of four patients with a subepidermal bullous disease associated with psoriasis were carried out to determine the true nature of the blistering disease and to investigate further the relationship between psoriasis and acquired subepidermal bullous diseases. Autoantibodies in all four patients bound to the epidermal side of salt-split skin by indirect immunofluorescence and detected the major bullous pemphigoid (BP) antigens by immunoblotting. One had additional IgA autoantibodies binding an epidermal polypeptide of 270/280 kDa and another had circulating IgG autoantibodies which detected both BP and epidermolysis bullosa acquisita (EBA) antigens. All patients had active psoriasis at the onset of the bullous disease. Three patients were being treated with tar when blisters developed; one patient also received UVB radiation and experienced a relapse after exposure to sunlight. HLA phenotypes in three patients were determined. All the patients responded well to methotrexate. These findings demonstrate that BP is the subepidermal bullous disease most associated with psoriasis. Changes at the basement membrane zone in psoriasis may be responsible for the heterogeneous antibody re...Continue Reading

References

Jun 1, 1977·Archives of Dermatology·A R Ahmed, N W Winkler
Oct 1, 1978·The British Journal of Dermatology·D V Hamilton, A W McKenzie
Nov 1, 1976·The British Journal of Dermatology·J R Person, R S Rogers
Nov 1, 1976·The British Journal of Dermatology·K Thomsen, H Schmidt
Sep 1, 1991·Clinical and Experimental Dermatology·W D SmithM U Fernando
Dec 1, 1991·Journal of the American Academy of Dermatology·M NayarC J Taylor
May 1, 1991·International Journal of Dermatology·V Ruocco, G Sacerdoti
Sep 1, 1991·The British Journal of Dermatology·A L DavisF Wojnarowska
Jan 1, 1991·Journal of the American Academy of Dermatology·J P BoixedaA Ledo
Apr 1, 1989·Journal of the American Academy of Dermatology·B M HislerE J Rudner
May 1, 1989·Clinical and Experimental Dermatology·A W Macfarlane, J L Verbov
Jul 1, 1989·Clinical and Experimental Dermatology·V A VenningF Wojnarowska
Aug 1, 1985·Journal of the American Academy of Dermatology·M H GrunwaldE J Feuerman
Sep 1, 1985·The British Journal of Dermatology·C E Grattan
Sep 1, 1985·Journal of the American Academy of Dermatology·T Henseler, E Christophers
Dec 1, 1972·Archives of Dermatology·D L Cram, K Fukuyama
Apr 19, 1984·The New England Journal of Medicine·D T WoodleyW R Gammon
Feb 1, 1980·The British Journal of Dermatology·A TiilikainenM Julin
Jan 1, 1995·Clinical and Experimental Dermatology·N SheerinD A Burns
Nov 1, 1993·The British Journal of Dermatology·M SatoH Tagami
Jan 1, 1994·Archives of Dermatological Research·T MuramatsuT Ohnishi
Jul 1, 1994·The British Journal of Dermatology·P PilettaJ H Saurat
Oct 1, 1993·Clinics in Dermatology·M J Fellner
Jun 1, 1994·Journal of the American Academy of Dermatology·S VassilevaN Tsankov
Sep 1, 1993·Contact Dermatitis·N AtakanA Karaduman
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND

❮ Previous
Next ❯

Citations

Jul 23, 1998·Journal of the American Academy of Dermatology·E J Primka, C Camisa
Nov 14, 2001·Clinics in Dermatology·F WojnarowskaN Khumalo
May 16, 2000·Journal of Dermatological Science·Y KawaharaT Nishikawa
Mar 29, 2000·The British Journal of Dermatology·Y TakagiM Niimura
Mar 29, 2000·The British Journal of Dermatology·U JappeH Gollnick
Aug 8, 2001·Clinical and Experimental Dermatology·A M Powell, M M Black
Feb 12, 1998·The British Journal of Dermatology·Y EndoT Hashimoto
Jun 15, 2011·American Journal of Clinical Dermatology·Efstathios RallisElma Koumantaki-Mathioudaki
Nov 7, 2012·Indian Dermatology Online Journal·Raghavendra RaoBalachandran Chandrashekar
Dec 6, 2011·Clinics in Dermatology·Giovanni Di ZenzoLuca Borradori
Feb 11, 1998·The Journal of Investigative Dermatology·L S ChanK B Gordon
Dec 28, 2007·Advances in Dermatology·Giovanni Di ZenzoLuca Borradori
Oct 4, 2005·Clinical and Experimental Dermatology·N CookeJ Alderdice
Mar 10, 2004·Journal of Cutaneous Pathology·Carla Sanchez-Palacios, Lawrence S Chan
Nov 2, 2006·International Journal of Dermatology·Agnes Wilczek, Michael Sticherling
Apr 27, 2007·Clinical and Experimental Dermatology·D HoshinaH Shimizu
Apr 27, 2011·The British Journal of Dermatology·Y J ChenH N Liu
Nov 3, 2009·Journal of Cellular and Molecular Medicine·Gheorghe HundorfeanCassian Sitaru
May 29, 2010·The Journal of Dermatology·Norito IshiiTakashi Hashimoto
Dec 3, 1999·The British Journal of Dermatology·E MoritaS Yamamoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.